Tian'an Technology Group Ltd. (TANAF)
OTCMKTS · Delayed Price · Currency is USD
13.80
-0.20 (-1.43%)
At close: Jun 24, 2025
Tian'an Technology Group Revenue
In the year 2024, Tian'an Technology Group had annual revenue of $1.78M with 623.03% growth. Tian'an Technology Group had revenue of $1.65M in the half year ending December 31, 2024, with 743.18% growth.
Revenue
1.78M
Revenue Growth
+623.03%
P/S Ratio
352.27
Revenue / Employee
222.89K
Employees
8
Market Cap
628.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.78M | 1.54M | 623.03% |
| Dec 31, 2023 | 246.62K | 50.89K | 26.00% |
| Dec 31, 2022 | 195.73K | 158.67K | 428.08% |
| Dec 31, 2021 | 37.07K | 10.76K | 40.88% |
| Dec 31, 2020 | 26.31K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |
| BioStem Technologies | 332.45M |